National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments
|Study ID||Alternative Stable ID||Type|
The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy, through identification of genomic changes associated with the following childhood cancers:
- Acute Lymphoblastic Leukemia (ALL) - A fast-growing type of blood cancer in which too many immature white blood cells are found in the blood and bone marrow.
- Acute Myeloid Leukemia (AML) - Another type of blood cancer marked by too many myeloblasts, an alternate type of immature white blood cell, are found in the blood and bone marrow.
- Neuroblastoma (NBL) - Cancer of cells of the sympathetic nervous system.
- Osteosarcoma (OS) - A cancer of the bone that primarily affects children and adolescents.
- Wilms' Tumor (WT) - A cancer of cells in the kidney that can spread to the liver, lung and lymph nodes.
*Additional renal and AML tumors are being added to the TARGET Initiative (clear cell sarcoma ... (Show More)